Order Center
 
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Product Lines
Product Highlights
New Literature
Ion Channels
Key Resources
Cell Signaling Web Tools
New Products
PathFinder
Pathway Slides & Charts
Pharm. Action Table
Poster Gallery
Protocols
Search Tools
eHandbook
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 

Drug Activation of Dopaminergic Neurons

Top Border
Left Border  Right Border
Left Corner Back Download Forward Sigma-Aldrich Right Corner

Drug Activation of Dopaminergic Neurons

The main mechanism responsible for the reinforcing properties of most abused drugs is the direct or indirect activation of dopaminergic neurons in the ventral tegmental area (VTA). This figure represents a dopaminergic neuron in the VTA as well as a GABAergic interneuron and a GABAergic projection neuron with a recurrent collateral. Whereas, nicotine increases the firing rate of dopaminergic neurons in the VTA by activating nicotinic acetylcholine receptors located on these cells, other drugs of abuse activate dopaminergic neurotransmission by inhibiting GABAergic transmission in the VTA. Stimulation of m opioid receptors, GABAA receptors, or CB1 cannabinoid receptors on VTA GABAergic neurons reduces GABA transmission, which increases the firing rate of dopaminergic neurons via disinhibition.

Back to Top


Site Use Terms Terms and Conditions of Sale Privacy Business Development Contact Us
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved.
Reproduction of any materials from the site is strictly forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.